These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 16879774

  • 1. Angiogenetic factors and biochemical markers of bone metabolism in POEMS syndrome treated with high-dose therapy and autologous stem cell support.
    Kastritis E, Terpos E, Anagnostopoulos A, Xilouri I, Dimopoulos MA.
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):73-6. PubMed ID: 16879774
    [Abstract] [Full Text] [Related]

  • 2. Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton.
    Mountzios G, Dimopoulos MA, Bamias A, Papadopoulos G, Kastritis E, Syrigos K, Pavlakis G, Terpos E.
    Acta Oncol; 2007 Jul; 46(2):221-9. PubMed ID: 17453373
    [Abstract] [Full Text] [Related]

  • 3. Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS).
    Politou M, Terpos E, Anagnostopoulos A, Szydlo R, Laffan M, Layton M, Apperley JF, Dimopoulos MA, Rahemtulla A.
    Br J Haematol; 2004 Sep; 126(5):686-9. PubMed ID: 15327520
    [Abstract] [Full Text] [Related]

  • 4. Imbalance of the osteoprotegerin/RANKL ratio in bone marrow microenvironment after allogeneic hemopoietic stem cell transplantation.
    Ricci P, Tauchmanova L, Risitano AM, Carella C, Mazziotti G, Lombardi G, Colao A, Rotoli B, Selleri C.
    Transplantation; 2006 Dec 15; 82(11):1449-56. PubMed ID: 17164716
    [Abstract] [Full Text] [Related]

  • 5. Bone turnover and the osteoprotegerin-RANKL pathway in tumor-induced osteomalacia: a longitudinal study of five cases.
    Rendina D, De Filippo G, Tauchmanovà L, Insabato L, Muscariello R, Gianfrancesco F, Esposito T, Cioffi M, Colao A, Strazzullo P, Mossetti G.
    Calcif Tissue Int; 2009 Oct 15; 85(4):293-300. PubMed ID: 19763378
    [Abstract] [Full Text] [Related]

  • 6. Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: impact of autologous hematopoietic stem cell transplantation.
    Barete S, Mouawad R, Choquet S, Viala K, Leblond V, Musset L, Amoura Z, Khayat D, Francès C.
    Arch Dermatol; 2010 Jun 15; 146(6):615-23. PubMed ID: 20566924
    [Abstract] [Full Text] [Related]

  • 7. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
    Stilgren LS, Rettmer E, Eriksen EF, Hegedüs L, Beck-Nielsen H, Abrahamsen B.
    Bone; 2004 Jul 15; 35(1):256-65. PubMed ID: 15207766
    [Abstract] [Full Text] [Related]

  • 8. Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis.
    Reyes-García R, Muñoz-Torres M, García DF, Mezquita-Raya P, García Salcedo JA, de Dios Luna J.
    Menopause; 2010 Jul 15; 17(1):140-4. PubMed ID: 19574937
    [Abstract] [Full Text] [Related]

  • 9. Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept.
    Woo JH, Lee HJ, Sung IH, Kim TH.
    J Rheumatol; 2007 Aug 15; 34(8):1753-9. PubMed ID: 17610317
    [Abstract] [Full Text] [Related]

  • 10. Marked recovery of severe renal lesions in POEMS syndrome with high-dose melphalan therapy supported by autologous blood stem cell transplantation.
    Sanada S, Ookawara S, Karube H, Shindo T, Goto T, Nakamichi T, Saito M, Matsubara M, Suzuki M.
    Am J Kidney Dis; 2006 Apr 15; 47(4):672-9. PubMed ID: 16564945
    [Abstract] [Full Text] [Related]

  • 11. Changes in the serum sex steroids, IL-7 and RANKL-OPG system after bone marrow transplantation: influences on bone and mineral metabolism.
    Baek KH, Oh KW, Lee WY, Tae HJ, Rhee EJ, Han JH, Cha BY, Kim YJ, Lee KW, Son HY, Kang SK, Kim CC, Kang MI.
    Bone; 2006 Dec 15; 39(6):1352-60. PubMed ID: 16905375
    [Abstract] [Full Text] [Related]

  • 12. Osteoprotegerin and RANKL in alcoholic liver cirrhosis.
    Fábrega E, Orive A, García-Suarez C, García-Unzueta M, Antonio Amado J, Pons-Romero F.
    Liver Int; 2005 Apr 15; 25(2):305-10. PubMed ID: 15780054
    [Abstract] [Full Text] [Related]

  • 13. Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.
    Martini G, Gennari L, Merlotti D, Salvadori S, Franci MB, Campagna S, Avanzati A, De Paola V, Valleggi F, Nuti R.
    Bone; 2007 Feb 15; 40(2):457-63. PubMed ID: 16979395
    [Abstract] [Full Text] [Related]

  • 14. Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women.
    Kim JG, Kim JH, Lee DO, Kim H, Kim JY, Suh CS, Kim SH, Choi YM.
    Menopause; 2008 Feb 15; 15(2):357-62. PubMed ID: 17925661
    [Abstract] [Full Text] [Related]

  • 15. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin in men with thyroid cancer.
    Mikosch P, Igerc I, Kudlacek S, Woloszczuk W, Gallowitsch HJ, Kresnik E, Stettner H, Grimm G, Lind P, Pietschmann P.
    Eur J Clin Invest; 2006 Aug 15; 36(8):566-73. PubMed ID: 16893379
    [Abstract] [Full Text] [Related]

  • 16. POEMS syndrome treated with melphalan high-dose therapy and autologous blood stem cell transplantation: a single-institution experience.
    Thoennissen GB, Thoennissen NH, Fritz F, Hilbig A, Kerkhoff A, Liersch R, Krug U, Koschmieder S, Müller-Tidow C, Mesters R, Kropff M, Berdel WE.
    Ann Hematol; 2012 Sep 15; 91(9):1419-25. PubMed ID: 22543828
    [Abstract] [Full Text] [Related]

  • 17. Serum osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study.
    Giusti M, Cecoli F, Fazzuoli L, De Franchis V, Ceresola E, Ferone D, Mussap M, Minuto F.
    Metabolism; 2007 May 15; 56(5):699-707. PubMed ID: 17445547
    [Abstract] [Full Text] [Related]

  • 18. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.
    Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Pilla P, Biondi B, Iorio S, Giustina A, Amato G, Carella C.
    J Bone Miner Res; 2005 Mar 15; 20(3):480-6. PubMed ID: 15746993
    [Abstract] [Full Text] [Related]

  • 19. Effects of relaxin and estrogens on bone remodeling markers, receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), in rat adjuvant-induced arthritis.
    Ho TY, Santora K, Chen JC, Frankshun AL, Bagnell CA.
    Bone; 2011 Jun 01; 48(6):1346-53. PubMed ID: 21419242
    [Abstract] [Full Text] [Related]

  • 20. Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome.
    Kuwabara S, Misawa S, Kanai K, Suzuki Y, Kikkawa Y, Sawai S, Hattori T, Nishimura M, Nakaseko C.
    Neurology; 2008 Nov 18; 71(21):1691-5. PubMed ID: 18832140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.